Biotechnology - Techseriesinsight

January 30, 2026
Business Wire
Biotechnology, News

Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System

Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the...

January 30, 2026
PRNewswire
Biotechnology, News

Piramal Pharma Limited Announces Results for Q3 and 9M FY26

Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceutical, health and wellness company, today announced its standalone and consolidated results for the Third Quarter (Q3) and Nine...

January 29, 2026
Business Wire
Biotechnology, News

Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2025 Results

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2025. Fourth...

January 29, 2026
PRNewswire
Biotechnology, News

LifeArc Ventures 2025: New geographies and investments, a growing team and continued portfolio progress

The venture capital arm of the medical research organisation, LifeArc, had its most active year to date in 2025, announcing investments in four new innovative life sciences portfolio companies...

January 28, 2026
Business Wire
Biotechnology, News

Premier Radiology Services Acquires NRAD, Further Expanding Teleradiology Capabilities

Premier Radiology Services (Premier) is pleased to announce the acquisition of National Radiology Solutions (NRAD), a highly regarded teleradiology provider recognized for its diverse team of specialists and deep...

January 28, 2026
PRNewswire
Biotechnology, News

Bio-Techne Launches Simple Plex Ultra-Sensitive Assays on Ella Platform to Enable Femtogram-Level Detection of Neurological Biomarkers

A global provider of life science tools, reagents, and diagnostic products, today announced the launch of Simple Plex Ultra-Sensitive Assays on the Ella automated benchtop platform. Early detection of neurodegenerative...

January 27, 2026
Business Wire
Biotechnology, News

Tubulis Adds Steve Kelsey as Independent Director to its Advisory Board

The appointment of Steve Kelsey, MD, as independent director to its Advisory Board. Dr. Kelsey, currently President, Research and Development at Revolution Medicines, brings more than two decades of...

January 27, 2026
PRNewswire
Biotechnology, News

Libevitug Approved in China as First-in-Class Hepatitis D Treatment

Huahui Health announced that China National Medical Products Administration (NMPA) has granted conditional approval to its Libevitug injection for the treatment of chronic hepatitis D virus infection in adults with...

January 23, 2026
Business Wire
Biotechnology, News

ImmunityBio Reports Median Overall Survival Not Yet Reached and Lymphopenia Reversed in Recurrent Glioblastoma Patients Receiving ANKTIVA® Plus CAR-NK, Chemo-Free Therapy

A commercial-stage immunotherapy company developing cytokine and cellular immunotherapies designed to restore immune competence, today announced updated Phase 2 clinical results from QUILT 3.078 (NCT06061809), evaluating a chemotherapy-free combination...

January 22, 2026
Business Wire
Biotechnology, News

Vizient State of the Industry Report: Healthcare Faces a Reset in 2026 and Beyond

Foundational pressures — including affordability concerns, workforce shortages, capacity constraints and shifting payer dynamics — are intensifying, according to the report. In response, many healthcare organizations are demonstrating resilience,...